Obalon Therapeutics (OBLN) Commences $35M Offering of Common Stock

January 16, 2018 4:01 PM EST Send to a Friend
Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled intragastric ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login